BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 28827372)

  • 1. Monocarboxylate Transporter MCT1 Promotes Tumor Metastasis Independently of Its Activity as a Lactate Transporter.
    Payen VL; Hsu MY; Rädecke KS; Wyart E; Vazeille T; Bouzin C; Porporato PE; Sonveaux P
    Cancer Res; 2017 Oct; 77(20):5591-5601. PubMed ID: 28827372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocarboxylate transporter 1 contributes to growth factor-induced tumor cell migration independent of transporter activity.
    Gray AL; Coleman DT; Shi R; Cardelli JA
    Oncotarget; 2016 May; 7(22):32695-706. PubMed ID: 27127175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells.
    Izumi H; Takahashi M; Uramoto H; Nakayama Y; Oyama T; Wang KY; Sasaguri Y; Nishizawa S; Kohno K
    Cancer Sci; 2011 May; 102(5):1007-13. PubMed ID: 21306479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose deprivation increases monocarboxylate transporter 1 (MCT1) expression and MCT1-dependent tumor cell migration.
    De Saedeleer CJ; Porporato PE; Copetti T; Pérez-Escuredo J; Payen VL; Brisson L; Feron O; Sonveaux P
    Oncogene; 2014 Jul; 33(31):4060-8. PubMed ID: 24166504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-124 Suppresses Pancreatic Ductal Adenocarcinoma Growth by Regulating Monocarboxylate Transporter 1-Mediated Cancer Lactate Metabolism.
    Wu DH; Liang H; Lu SN; Wang H; Su ZL; Zhang L; Ma JQ; Guo M; Tai S; Yu S
    Cell Physiol Biochem; 2018; 50(3):924-935. PubMed ID: 30355947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocarboxylate Transporters MCT1 and MCT4 Regulate Migration and Invasion of Pancreatic Ductal Adenocarcinoma Cells.
    Kong SC; Nøhr-Nielsen A; Zeeberg K; Reshkin SJ; Hoffmann EK; Novak I; Pedersen SF
    Pancreas; 2016 Aug; 45(7):1036-47. PubMed ID: 26765963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of MCT1 inhibits tumor growth, metastasis and enhances chemotherapeutic efficacy in osteosarcoma through regulation of the NF-κB pathway.
    Zhao Z; Wu MS; Zou C; Tang Q; Lu J; Liu D; Wu Y; Yin J; Xie X; Shen J; Kang T; Wang J
    Cancer Lett; 2014 Jan; 342(1):150-8. PubMed ID: 24012639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of monocarboxylate transporter 1 inhibits the invasion and migration through suppression of the PI3K/Akt signaling pathway in human nasopharyngeal carcinoma cells.
    Zhang P; Ma J; Gao J; Liu F; Sun X; Fang F; Zhao S; Liu H
    J Bioenerg Biomembr; 2018 Aug; 50(4):271-281. PubMed ID: 29882205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA interference targeting CD147 inhibits the proliferation, invasiveness, and metastatic activity of thyroid carcinoma cells by down-regulating glycolysis.
    Huang P; Chang S; Jiang X; Su J; Dong C; Liu X; Yuan Z; Zhang Z; Liao H
    Int J Clin Exp Pathol; 2015; 8(1):309-18. PubMed ID: 25755717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro and In Vivo Efficacy of the Monocarboxylate Transporter 1 Inhibitor AR-C155858 in the Murine 4T1 Breast Cancer Tumor Model.
    Guan X; Bryniarski MA; Morris ME
    AAPS J; 2018 Nov; 21(1):3. PubMed ID: 30397860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise-induced changes in tumour LDH-B and MCT1 expression are modulated by oestrogen-related receptor alpha in breast cancer-bearing BALB/c mice.
    Aveseh M; Nikooie R; Aminaie M
    J Physiol; 2015 Jun; 593(12):2635-48. PubMed ID: 25907793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperpolarized [1-
    Rao Y; Gammon S; Zacharias NM; Liu T; Salzillo T; Xi Y; Wang J; Bhattacharya P; Piwnica-Worms D
    Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22378-22389. PubMed ID: 32839325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Uptake of MCT1 Inhibitors AR-C155858 and AZD3965 and Their Effects on MCT-Mediated Transport of L-Lactate in Murine 4T1 Breast Tumor Cancer Cells.
    Guan X; Rodriguez-Cruz V; Morris ME
    AAPS J; 2019 Jan; 21(2):13. PubMed ID: 30617815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional activity of a monocarboxylate transporter, MCT1, in the human retinal pigmented epithelium cell line, ARPE-19.
    Majumdar S; Gunda S; Pal D; Mitra AK
    Mol Pharm; 2005; 2(2):109-17. PubMed ID: 15804185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocarboxylate Transporter 1 in Brain Diseases and Cancers.
    Sun Y; Sun J; He Z; Wang G; Wang Y; Zhao D; Wang Z; Luo C; Tian C; Jiang Q
    Curr Drug Metab; 2019; 20(11):855-866. PubMed ID: 31631816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of monocarboxylate transporter MCT1 expression by p53 mediates inward and outward lactate fluxes in tumors.
    Boidot R; Végran F; Meulle A; Le Breton A; Dessy C; Sonveaux P; Lizard-Nacol S; Feron O
    Cancer Res; 2012 Feb; 72(4):939-48. PubMed ID: 22184616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance.
    Quanz M; Bender E; Kopitz C; Grünewald S; Schlicker A; Schwede W; Eheim A; Toschi L; Neuhaus R; Richter C; Toedling J; Merz C; Lesche R; Kamburov A; Siebeneicher H; Bauser M; Hägebarth A
    Mol Cancer Ther; 2018 Nov; 17(11):2285-2296. PubMed ID: 30115664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4.
    Hong CS; Graham NA; Gu W; Espindola Camacho C; Mah V; Maresh EL; Alavi M; Bagryanova L; Krotee PAL; Gardner BK; Behbahan IS; Horvath S; Chia D; Mellinghoff IK; Hurvitz SA; Dubinett SM; Critchlow SE; Kurdistani SK; Goodglick L; Braas D; Graeber TG; Christofk HR
    Cell Rep; 2016 Feb; 14(7):1590-1601. PubMed ID: 26876179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The H+-linked monocarboxylate transporter (MCT1/SLC16A1): a potential therapeutic target for high-risk neuroblastoma.
    Fang J; Quinones QJ; Holman TL; Morowitz MJ; Wang Q; Zhao H; Sivo F; Maris JM; Wahl ML
    Mol Pharmacol; 2006 Dec; 70(6):2108-15. PubMed ID: 17000864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis.
    Sonveaux P; Copetti T; De Saedeleer CJ; Végran F; Verrax J; Kennedy KM; Moon EJ; Dhup S; Danhier P; Frérart F; Gallez B; Ribeiro A; Michiels C; Dewhirst MW; Feron O
    PLoS One; 2012; 7(3):e33418. PubMed ID: 22428047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.